Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 5,914 shares at $30.10 ($178K) on 2023-02-13, disclosed to the SEC on 2023-02-14.
Open-market sale of $178k DNLI by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.80 | 818 | $24K | 13.7% |
| 2 | $30.10 | 2,548 | $77K | 43.1% |
| 3 | $30.10 | 2,548 | $77K | 43.1% |
| Total | $30.06 avg | 5,914 | $178K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |